DEXYCU (Dexamethasone Intraocular Suspension) 9% Retrospective Study 001

Completed

Conditions studied: Cataract

In brief

Retrospective study to provide clinical outcomes with DEXYCU (dexamethasone intraocular suspension) 9%.

Key facts

Study ID
NCT04290676
Run by
EyePoint Pharmaceuticals, Inc.
People needed
527
Starts
2019-11-13
Expected to finish
2020-05-01
Last updated by the study team
2021-05-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.